10x Genomics (TXG) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $36.2 million.
- 10x Genomics' Accumulated Depreciation & Amortization rose 89.19% to $36.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $36.2 million, marking a year-over-year increase of 89.19%. This contributed to the annual value of $36.2 million for FY2025, which is 89.19% up from last year.
- 10x Genomics' Accumulated Depreciation & Amortization amounted to $36.2 million in Q4 2025, which was up 89.19% from $26.1 million recorded in Q3 2025.
- 10x Genomics' Accumulated Depreciation & Amortization's 5-year high stood at $36.2 million during Q4 2025, with a 5-year trough of $4.8 million in Q1 2021.
- For the 5-year period, 10x Genomics' Accumulated Depreciation & Amortization averaged around $19.4 million, with its median value being $18.2 million (2024).
- As far as peak fluctuations go, 10x Genomics' Accumulated Depreciation & Amortization soared by 5194.17% in 2021, and later plummeted by 1281.59% in 2025.
- 10x Genomics' Accumulated Depreciation & Amortization (Quarter) stood at $21.1 million in 2021, then increased by 20.13% to $25.4 million in 2022, then soared by 39.99% to $35.5 million in 2023, then rose by 1.03% to $35.9 million in 2024, then rose by 0.89% to $36.2 million in 2025.
- Its Accumulated Depreciation & Amortization was $36.2 million in Q4 2025, compared to $26.1 million in Q3 2025 and $15.8 million in Q2 2025.